AZGP1 and metastatic malignant neoplasm in the lymph nodes: AZGP1 and MUC1 were first identified as candidate markers of PCa aggressiveness by a study that used cDNA microarrays to compare gene expression in fresh-frozen radical prostatectomy specimens, fresh-frozen “normal” prostate tissue from these same surgical specimens, and lymph node metastases 25.